CD8A and neoplasm: CD8+ T cells are activated via the recognition of tumor antigens through the T cell receptor (TCR) and rapidly proliferate and differentiate into the cytotoxic T cells, resulting in the elimination of tumor cells via cell-cell contact, which accounts for the higher infiltration levels of CD8+ T cells in low-risk group.